Results

Total Results: 3,062 records

Showing results for "disease".

201. Strategies to Better Manage Lipids – Statin Pearls
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/evidencenow/heart-health/strategies-to-better-manage-lipids.pptx
     November 01, 2016 - High risk is defined as: Having a diagnosis of atherosclerotic cardiovascular disease Ever having an … 10-year CVD event risk of ≥10% The USPSTF recommends that adults without a history of cardiovascular disease … (CVD) (i.e., symptomatic coronary artery disease or thrombotic stroke) use a low- to moderate-dose statin … CVD event risk of less than 10%, the likelihood of benefit is smaller due to a lower probability of disease

202. Final Progress Report: Prescription Opioid Use Trajectories and Risk Factors Associated with Opioid-Related Hospitalizations in Older Adults (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/2024-02/wei-report.pdf
     January 01, 2024 - Mental health conditions, cardiovascular diseases, and kidney disease were significant predisposing … , hypertension, pulmonary condition, kidney disease, gastrointestinal tract disorder, and liver disease … Opioid-Related Hospitalization and Its Association With Chronic Diseases: Findings From the National … Trends in invasive pneumococcal disease-associated hospitalizations. … Opioid Analgesic Use and Risk for Invasive Pneumococcal Diseases: A Nested Case-Control Study.

203. Community-Acquired Pneumonia Clinical Decision Support Training: Primary Care
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/quality-resources/tools/cap-toolkit/tool4b_pc-setting.pptx
     January 10, 2017 - Table of Contents Context Background on Community-Acquired Pneumonia (CAP) Infectious Diseases Society … Centers for Disease Control and Prevention. … Centers for Disease Control and Prevention (CDC). http://www.cdc.gov/nchs/data/nvsr/nvsr64/nvsr64_02. … Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management … Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management

204. Aspirin for Secondary & Primary Prevention of ASCVD | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/evidencenow/heart-health/aspirin/prevention.html
     September 01, 2018 - Prevention and Risk Reduction Therapy for Patients with Coronary and Other Atherosclerotic Vascular Disease … guideline, published in Circulation in 2011, for prescribing aspirin for secondary prevention of heart disease

205. Aspirin for Secondary Prevention of ASCVD: Guideline | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/evidencenow/heart-health/aspirin/treatment.html
     August 01, 2018 - Secondary and Primary Prevention of ASCVD Resource description: This presentation explains heart disease … and the use of aspirin for primary and secondary prevention of heart disease.

206. EvidenceNow Executive Summary - New York City Cooperative (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/evidencenow/cooperatives/evidencenow-executive-summary-nyc.pdf
     November 01, 2017 - care practices have the evidence they need to help their patients adopt the ABCS of cardiovascular disease … the most diverse (29 percent Hispanic, 25.5 percent African American, and 13 percent Asian).1 Heart disease … is the primary cause of death in the city, and prevalence of cardiovascular disease (CVD) risk factors … .2 Residents of the poorest neighborhoods consistently have higher mortality rates from almost all diseases … • Using Practice Facilitation in primary care settings to reduce risk factors for cardiovascular disease

207. Appendix B. Clinical Materials to Share With Primary Care Providers | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/patient-safety/settings/hospital/resource/nicu/packet/apb.html
     December 01, 2013 - Infants with significant respiratory disease or congenital heart disease may need a hematocrit maintained … If the baby is very fluid sensitive (e.g., chronic lung disease), IV lasix 1 mg/kg immediately after … Complications Long term TPN use: Hepatobiliary disease. Catheter-associated sepsis. … Criteria for laser therapy or cryotherapy: Zone 2: plus disease with stage 2 or 3 ROP. … Zone 1: plus disease with any stage ROP. Zone 1: stage 3 ROP with no plus disease.

208. Chartbook on Women's Health Care: Slide Presentation | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/research/findings/nhqrdr/2014chartbooks/womenhealth/womenh-slides.html
     March 01, 2020 - Slide 13 Chronic Disease in Women Evidence demonstrates that chronic disease affects women and … Diseases and National Center for Health Statistics, National Immunization Survey—Teen, 2008-2012. … Control and Prevention, National Center for Immunizations and Respiratory Diseases and National Center … Centers for Disease Control and Prevention. … https://www.lung.org/lung-health-diseases/lung-disease-lookup/copd/learn-about-copd .

209. Section 1, Tables 1 and 2 (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-229-section-1-tables-1-2.pdf
     February 09, 2018 - percentile for age in the absence of external vagal stimulus, β- blocker drugs, or congenital heart disease … normal for age or mechanical ventilation for an acute process not related to underlying neuromuscular disease … to peripheral temperature gap > 3°C Respiratory • PaO2/FIO2 < 300 in absence of cyanotic heart disease … or preexisting lung disease OR • PaCO2 > 65 torr or 20 mm Hg over baseline PaCO2 OR • Proven

210. Section 1, Tables 1 and 2 (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0231-section-1-tables-1-2.pdf
     April 26, 2018 - percentile for age in the absence of external vagal stimulus, β- blocker drugs, or congenital heart disease … normal for age or mechanical ventilation for an acute process not related to underlying neuromuscular disease … Core to peripheral temperature gap > 3°C Respiratory • PaO2/FIO2 < 300 in absence of cyanotic heart disease … or preexisting lung disease OR • PaCO2 > 65 torr or 20 mm Hg over baseline PaCO2 OR • Proven need

211. Section 1, Tables 1 and 2 (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-228-tables-1-2.pdf
     February 12, 2018 - percentile for age in the absence of external vagal stimulus, β-blocker drugs, or congenital heart disease … normal for age or mechanical ventilation for an acute process not related to underlying neuromuscular disease … Core to peripheral temperature gap > 3°C Respiratory • PaO2/FIO2 < 300 in absence of cyanotic heart disease … or preexisting lung disease OR • PaCO2 > 65 torr or 20 mm Hg over baseline PaCO2 OR • Proven need

212. Anticipatory Guidance Regarding Hydroxyurea Treatment for Children With Sickle Cell Anemia (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-213-fullreport.pdf
     January 01, 2019 - SCA is the most serious form of sickle cell disease (SCD). … This measure is part of the Q-METRIC Sickle Cell Disease Record Data set. 3. … addressing childhood obesity may have implications for the subsequent development of cardiovascular diseases … Population estimates of sickle cell disease in the U.S. … The management of sickle cell disease.

213. 5 Tk2 P1T3-Checklist For Discussion With Local Hospitals Providers Ers Phase 1 (doc file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/nhguide/5_TK2_P1T3-Checklist_for_Discussion_with_Local_Hospitals_Providers_ERs_Phase_1.doc
     May 01, 2014 - reasonable to reach out also to hospital staff involved in microbiology, infection control, and infectious diseases … ______________________ Email Address ___________________________ Yes No Infectious diseases … These physicians treat patients with infectious diseases and may have important clinical input regarding … the antibiogram to frontline clinicians (Emergency Department physicians, hospitalists, infectious disease

214. EvidenceNOW: New York City Cooperative | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/evidencenow/projects/heart-health/about/cooperatives/nyc.html
     March 01, 2021 - care practices have the evidence they need to help their patients adopt the ABCS of cardiovascular disease … the most diverse (29 percent Hispanic, 25.5 percent African American, and 13 percent Asian). 1 Heart disease … is the primary cause of death in the city, and prevalence of cardiovascular disease (CVD) risk factors … 2 Residents of the poorest neighborhoods consistently have higher mortality rates from almost all diseases … Facilitation in a Cluster Randomized Stepped Wedge Design Trial to Improve Adherence to Cardiovascular Disease

215. Appendix A. References | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/research/findings/final-reports/stpra/stpraaparef.html
     September 01, 2018 - Scandinavian Journal of Infectious Diseases 39.10 (2007): 890-95. Print. … Clinical Infectious Diseases , 44(7):921, 2007. … Factors influencing wound healing after surgery for metastatic disease of the spine. … Centers for Disease Control. … Centers for Disease Control.

216. 5 Tk2 P4T2-Quality Improvement Review Tool For Antibiotic Use In Uti Phase 4 (doc file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/nhguide/5_TK2_P4T2-Quality_Improvement_Review_Tool_for_Antibiotic_Use_in_UTI_Phase_4.doc
     January 01, 2011 - Categories are based on the 2010 Infectious Diseases Society of America guidelines. … treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases … Society of America and the European Society for Microbiology and Infectious Diseases.

217. Section 6, Tables 5 and 6 (pdf file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-216-section-6-tables-5-6.pdf
     February 26, 2018 - Section 6, Tables 5 and 6 Table 5: Agreement and Kappa Statistics for Sickle Cell Disease for Inter‐Rater … Criterion 29 90% 0.79 Table 6: Appropriate Fever Management in the ED for Children with Sickle Cell Disease

218. Redesigning Primary Health Care Teams for Population Health and Quality Improvement | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/practiceimprovement/delivery-initiative/redesigningprimaryhealthcareteams.html
     November 01, 2017 - physicians' administrative burden, boost clinic capacity, and better support prevention and chronic disease … Therefore, patients may not receive all the preventive or chronic disease management services needed, … Standing orders were also created for chronic disease management and for routine referrals by CTMAs to … Training included disease-specific modules on hypertension, chronic heart failure, asthma, and diabetes … also an opportunity to discuss quality data reports, such as performance on immunizations, chronic disease

219. 3P_RD_AHRQ_PUF_Data_Dictionary (xls file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/data/3P-RD-Data-Dictionary.xlsx
     March 16, 2023 - secondary specialty in the CORE file Medical specialties include: Allergy/Immunology; Cardiovascular Disease … ; Nephrology; Infectious Disease; Endocrinology; Rheumatology; Addiction Medicine; Hematology; Hematology … Medical specialties include: Allergy/Immunology; Cardiovascular Disease (Cardiology); Interventional … Cardiology; Dermatology; Gastroenterology; Neurology; Cardiac Electrophysiology; Pulmonary Disease; Nephrology … ; Infectious Disease; Endocrinology; Rheumatology; Addiction Medicine; Hematology; Hematology/Oncology

220. Hospital-Acquired Pneumonia (doc file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/best-practices/HAP-one-page.docx
     November 01, 2019 - hospital-acquired and ventilator-associated pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases … Legionella (Legionnaire’s Disease and Pontiac Fever). Centers for Disease Control and Prevention. … National Center for Immunization and Infectious Diseases, Division of Bacterial Diseases. … April 30, 2018. https://www.cdc.gov/legionella/clinicians/disease-specifics.html.